Brazilian pharmaceutical company will open its facility in Ontario

| By | Drug Development, R&D

The Government of Ontario, Canada, is partnering with Biolab Pharma Ltd. to help the company retrofit its first international facility outside Brazil, creating 40 new highly skilled jobs in the province. 

Biolab Pharma develops, manufactures and commercializes prescription medicine and is a leader in cardiology and dermatology drugs. It is one of the ten largest pharmaceutical companies in Brazil.

With support from Ontario’s Jobs and Prosperity Fund, the company is retrofitting a 1200 m2 research development and innovation (RD&I) facility in Mississauga. It will also invest in new equipment and special software to improve its research capabilities. These enhancements will help the company develop and commercialize innovative products for the North American and European markets.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.